AP&T: Editors' Declarations of Interest

Editorial: Cephalosporin‐Induced Liver Injury—Interesting but Tricky. Authors' Reply
by: Raj Vuppalanchi, et al.
Published: (2025)

A Message From the Editors
by: Colin W. Howden, et al.
Published: (2024)

No value of non‐selective beta‐blockers after TIPS‐insertion
by: Anja Tiede, et al.
Published: (2024)

Editorial: The future of managing drug induced liver injury
by: Amanda Nicoll
Published: (2024)

Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply
by: Vibeke Strande, et al.
Published: (2024)

Impact of non‐selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score
by: Ting Wang, et al.
Published: (2024)

Correction to ‘Stromal Vascular Fraction With Platelet‐Rich Plasma Injection During Surgery is Feasible and Safe in Treatment‐Refractory Perianal Fistulising Crohn's Disease: A Pilot Study’
Published: (2024)

Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response
by: Jung Eun Park, et al.
Published: (2024)

Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
by: Pegah Golabi, et al.
Published: (2024)

Editorial: H. pylori Antimicrobial Susceptibility Testing—An Expanding Toolbox
by: Suvithan Rajadurai, et al.
Published: (2024)

Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply
by: Matthias Lenfant, et al.
Published: (2024)

Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice. Authors' reply
by: Eunice X. X. Tan, et al.
Published: (2024)

Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study
by: Kyuwon Kim, et al.
Published: (2024)

Editorial: Inflammation and Not Glucocorticoid Therapy is the Key Driver of Fracture Risk in IBD
by: Darcy Quinn Holt, et al.
Published: (2024)

Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing
by: Tomohiro Fukuda, et al.
Published: (2024)

Featured Cover
by: Tarek Hassanein, et al.
Published: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability?
by: Joshua Reid, et al.
Published: (2024)

Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis
by: Alfredo J. Lucendo, et al.
Published: (2024)

Other causes of neurocognitive impairment than covert hepatic encephalopathy ( CHE ) are very frequent, either alone or associated with CHE , in cirrhotic patients with cognitive complaints
by: Philippe Sultanik, et al.
Published: (2024)

A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
by: Maral Amangurbanova, et al.
Published: (2024)

Editorial: Extending upadacitinib induction dosing in ulcerative colitis—A delicate balance of efficacy and safety. Author's reply
by: Remo Panaccione
Published: (2024)

Editorial: Sounding the alarm—The rising global burden of adolescent and young adult alcohol‐related liver disease
by: Victoria T. Kronsten, et al.
Published: (2024)

Letter: Risks of proton pump inhibitor treatment in cirrhotic patients
by: Jiamei Wang, et al.
Published: (2024)

Issue Information
Published: (2024)

CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance
by: Hye Won Lee, et al.
Published: (2024)

Maladaptive weight control and eating behaviours in female adolescents/young adults are associated with increased risk of irritable bowel syndrome in adulthood: Results from the Growing Up Today Study (GUTS)
by: Keming Yang, et al.
Published: (2024)

Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound
by: Cathy Lu, et al.
Published: (2024)

Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non‐Liver Malignancies in Hepatitis B Endemic Areas
by: Yi‐Ping Hung, et al.
Published: (2024)

Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
by: Kee Huat Chuah, et al.
Published: (2024)

Factors Associated With Abdominal Pain in Patients With Active and Quiescent Ulcerative Colitis: A Multicohort Study
by: Tom van Gils, et al.
Published: (2024)

Global epidemiology of alcohol‐associated liver disease in adolescents and young adults
by: Pojsakorn Danpanichkul, et al.
Published: (2024)

Editorial: Novel insights into the prognostic relevance of high‐dose PPI treatment in patients with cirrhosis
by: Dominik Bettinger, et al.
Published: (2024)

Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV
by: Juan Macias, et al.
Published: (2024)

Letter: Optimising public health policies to combat alcohol‐associated liver disease in youth—Addressing key methodological and regional challenges
by: Rui Zhang, et al.
Published: (2024)

Editorial: Can dietary gluten restriction improve hepatic steatosis?
by: Hariklia Kranidioti, et al.
Published: (2024)

Review article: Prevention of inflammatory bowel disease—The path forward
by: Sérgio Bronze, et al.
Published: (2024)